FORM 10-K (12-31-15)

Company

AXIM BIOTECHNOLOGIES, INC.

Filed

April 14, 2016

Period of Report

December 31, 2015

Accession Number

0001387308-16-000187

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →